Visionary Holdings Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Life Sciences Segment Revenue Annually1.1MTarget: CAD 10,000,000+ annually for the Toronto Anti-Aging and High-End Medical Aesthetics Health Care Center
Total Revenue Annually5M
Net Income (Loss) Annually-15.8MTarget: Achieve profitability through strategic transformation
Watch Items
- Nasdaq Delisting Determination and Hearing ProcessTrigger: Staff Determination Letter received on June 4, 2026, due to delayed Form 6-K filingAction: Submit a formal request for a hearing before the Nasdaq Hearings Panel to challenge the delisting determination and stay the suspension.
- Negative Working Capital and Debt DefaultsTrigger: Negative working capital of $54.5 million and bank loan defaults as of March 31, 2025Action: Advance equity financing, negotiate debt restructuring, and secure temporary extension arrangements with creditors.
- Internal Control Over Financial Reporting (ICFR)Trigger: Ineffective internal controls due to lack of in-house US GAAP and SEC reporting expertiseAction: Hire qualified accounting personnel, implement continuous training, and establish an internal audit function.
Research as of 20 Jun 2026